Valuation: Simulations Plus, Inc.

Market Cap 37Cr 32Cr 30Cr 28Cr 52Cr 3.53TCr 53Cr 353.43Cr 138.38Cr 1.75TCr 138.99Cr 135.95Cr 5.9TCr P/E 2026 *
43.6x
P/E 2027 * 40x
Enterprise Value 37Cr 32Cr 30Cr 28Cr 52Cr 3.53TCr 53Cr 353.43Cr 138.38Cr 1.75TCr 138.99Cr 135.95Cr 5.9TCr EV / Sales 2026 *
4.52x
EV / Sales 2027 * 4.29x
Free-Float
83.08%
Yield 2026 *
-
Yield 2027 * -
1 day+0.08%
1 week-0.11%
Current month+0.05%
1 month-0.16%
3 months+22.87%
6 months+9.24%
Current year+0.49%
1 week 18.3
Extreme 18.3
18.39
1 month 18.19
Extreme 18.19
18.47
Current year 11.09
Extreme 11.09
21.01
1 year 11.09
Extreme 11.09
21.01
3 years 11.09
Extreme 11.09
52.69
5 years 11.09
Extreme 11.09
67.59
10 years 7.9
Extreme 7.9
90.92
Manager TitleAgeSince
Chief Executive Officer 67 26/06/2018
Director of Finance/CFO 63 01/12/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 81 17/07/1996
Director/Board Member 58 03/12/2014
Chairman 76 17/12/2024
Date Insider Type Main position Quantity % Market Cap.
06/07/26 Sell

Executive/Senior Manager

-1,000 0.0050%
01/07/26 Sell

Founder

-4,177 0.0207%
15/06/26 Fiscal year

Executive/Senior Manager

3,150 0.0156%
Change 5-day change 1-year change 3-year change Capi.($)
+0.08%-0.11%+40.71%-63.21% 37Cr
+1.99%+10.01%-27.91%+0.33% 3.27TCr
+0.94%+0.05%-49.27%+135.80% 1.18TCr
-2.44%+3.69%-24.08%+63.46% 562.92Cr
+1.80%+8.02% - - 222.76Cr
-1.13%-11.79%+16.62%-42.73% 168.77Cr
-2.92%+3.58% - - 179.85Cr
+3.26%+2.03%-32.81% - 101.49Cr
-1.47%+0.57%+34.30%+103.00% 87Cr
-0.88%+1.51%-41.97%-54.47% 77Cr
Average +0.06%+1.25%-10.55%+20.31% 588.79Cr
Weighted average by Cap. +1.02%+6.34%-29.56%+35.63%

Financials

2026 *2027 *
Net sales 8.19Cr 7.11Cr 6.6Cr 6.09Cr 11Cr 781.63Cr 12Cr 78Cr 31Cr 388.2Cr 31Cr 30Cr 1.31TCr 8.63Cr 7.49Cr 6.96Cr 6.42Cr 12Cr 823.5Cr 12Cr 82Cr 32Cr 408.99Cr 32Cr 32Cr 1.38TCr
Net income 95.34L 82.81L 76.9L 70.92L 1.34Cr 91Cr 1.36Cr 9.1Cr 3.56Cr 45Cr 3.58Cr 3.5Cr 152.02Cr 1.02Cr 88.43L 82.12L 75.74L 1.43Cr 97Cr 1.45Cr 9.72Cr 3.81Cr 48Cr 3.82Cr 3.74Cr 162.34Cr
Net Debt - -
Logo Simulations Plus, Inc.
Simulations Plus, Inc. specializes in model-informed and artificial intelligence (AI)-accelerated drug development. The Company helps its clients by accelerating the discovery, development, and commercialization of pharmaceuticals and other products through science-based software and consulting solutions. The Company’s segments include Software and Services. The Company's Software segment supports pharmaceutical research, development, and commercialization through simulation, modeling, and AI-driven prediction. Its main products include GastroPlus, ADMET Predictor, MonolixSuite, and others for disease modeling and training, as well as Pro-ficiency for clinical operations. Its Services segment includes advanced consulting services across the entire drug development lifecycle. Its scientists and engineers specialize in drug discovery, pharmacokinetics, pharmacodynamics, drug modeling, clinical trial data analysis, regulatory strategy, and medical communications.
Employees
213
Date Price Change Volume
31/26/31 $18.33 +0.16% 10,363
30/26/30 $18.30 -0.16% 2,15,369
29/26/29 $18.33 0.00% 3,46,154
28/26/28 $18.33 0.00% 1,58,846
27/26/27 $18.33 -0.05% 3,91,624
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
18.30USD
Average target price
17.25USD
Spread / Average Target
-5.74%

Quarterly revenue - Rate of surprise